<bill session="117" type="h" number="3" updated="2023-05-11T15:45:15Z">
  <state datetime="2021-04-22">REFERRED</state>
  <status>
    <introduced datetime="2021-04-22"/>
  </status>
  <introduced datetime="2021-04-22"/>
  <titles>
    <title type="display">Elijah E. Cummings Lower Drug Costs Now Act</title>
    <title type="official" as="introduced">To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.</title>
    <title type="short" as="introduced">Elijah E. Cummings Lower Drug Costs Now Act</title>
  </titles>
  <sponsor bioguide_id="P000034"/>
  <cosponsors>
    <cosponsor bioguide_id="A000376" joined="2021-05-28"/>
    <cosponsor bioguide_id="A000148" joined="2021-06-25"/>
    <cosponsor bioguide_id="B001300" joined="2021-04-26"/>
    <cosponsor bioguide_id="B001281" joined="2021-05-04"/>
    <cosponsor bioguide_id="B000574" joined="2021-04-26"/>
    <cosponsor bioguide_id="B001303" joined="2021-05-28"/>
    <cosponsor bioguide_id="B001304" joined="2021-07-20"/>
    <cosponsor bioguide_id="B001286" joined="2021-06-25"/>
    <cosponsor bioguide_id="C001112" joined="2021-05-20"/>
    <cosponsor bioguide_id="C001090" joined="2021-05-20"/>
    <cosponsor bioguide_id="C001055" joined="2021-04-26"/>
    <cosponsor bioguide_id="C001117" joined="2021-05-14"/>
    <cosponsor bioguide_id="C001066" joined="2021-05-04"/>
    <cosponsor bioguide_id="C001091" joined="2021-04-26"/>
    <cosponsor bioguide_id="C001084" joined="2021-09-22"/>
    <cosponsor bioguide_id="C001061" joined="2021-06-29"/>
    <cosponsor bioguide_id="C001068" joined="2022-01-25"/>
    <cosponsor bioguide_id="C001078" joined="2021-05-20"/>
    <cosponsor bioguide_id="C000754" joined="2021-05-14"/>
    <cosponsor bioguide_id="C001069" joined="2021-05-04"/>
    <cosponsor bioguide_id="C001119" joined="2021-05-14"/>
    <cosponsor bioguide_id="C001111" joined="2021-06-08"/>
    <cosponsor bioguide_id="D000096" joined="2021-04-26"/>
    <cosponsor bioguide_id="D000197" joined="2021-04-26"/>
    <cosponsor bioguide_id="D000623" joined="2021-05-14"/>
    <cosponsor bioguide_id="D000610" joined="2021-07-06"/>
    <cosponsor bioguide_id="D000624" joined="2021-04-26"/>
    <cosponsor bioguide_id="D000482" joined="2021-04-26"/>
    <cosponsor bioguide_id="E000296" joined="2021-04-26"/>
    <cosponsor bioguide_id="F000468" joined="2021-05-04"/>
    <cosponsor bioguide_id="F000462" joined="2021-05-28"/>
    <cosponsor bioguide_id="G000559" joined="2022-07-11"/>
    <cosponsor bioguide_id="G000587" joined="2021-06-08"/>
    <cosponsor bioguide_id="G000585" joined="2021-04-26"/>
    <cosponsor bioguide_id="H001081" joined="2021-04-26"/>
    <cosponsor bioguide_id="H001038" joined="2021-08-03"/>
    <cosponsor bioguide_id="H001066" joined="2021-04-26"/>
    <cosponsor bioguide_id="J000305" joined="2021-07-06"/>
    <cosponsor bioguide_id="K000009" joined="2021-04-26"/>
    <cosponsor bioguide_id="K000380" joined="2021-04-26"/>
    <cosponsor bioguide_id="K000394" joined="2021-09-17"/>
    <cosponsor bioguide_id="K000382" joined="2021-08-03"/>
    <cosponsor bioguide_id="L000559" joined="2021-07-20"/>
    <cosponsor bioguide_id="L000560" joined="2021-05-14"/>
    <cosponsor bioguide_id="L000557" joined="2021-04-26"/>
    <cosponsor bioguide_id="L000586" joined="2021-09-14"/>
    <cosponsor bioguide_id="L000582" joined="2021-05-20"/>
    <cosponsor bioguide_id="M000087" joined="2021-07-20"/>
    <cosponsor bioguide_id="M001185" joined="2021-05-28"/>
    <cosponsor bioguide_id="M001135" joined="2021-09-17"/>
    <cosponsor bioguide_id="M001143" joined="2021-06-08"/>
    <cosponsor bioguide_id="M001166" joined="2021-04-26"/>
    <cosponsor bioguide_id="M001188" joined="2022-07-14"/>
    <cosponsor bioguide_id="M000687" joined="2021-04-26"/>
    <cosponsor bioguide_id="M001160" joined="2021-05-04"/>
    <cosponsor bioguide_id="M001206" joined="2021-04-26"/>
    <cosponsor bioguide_id="N000179" joined="2021-08-06"/>
    <cosponsor bioguide_id="N000015" joined="2021-04-22"/>
    <cosponsor bioguide_id="N000191" joined="2021-08-03"/>
    <cosponsor bioguide_id="N000188" joined="2021-07-20"/>
    <cosponsor bioguide_id="N000147" joined="2021-05-04"/>
    <cosponsor bioguide_id="P000614" joined="2021-05-28"/>
    <cosponsor bioguide_id="P000616" joined="2022-07-11"/>
    <cosponsor bioguide_id="R000486" joined="2021-08-23"/>
    <cosponsor bioguide_id="R000576" joined="2021-05-20"/>
    <cosponsor bioguide_id="R000515" joined="2021-04-26"/>
    <cosponsor bioguide_id="R000577" joined="2021-05-28"/>
    <cosponsor bioguide_id="S001177" joined="2021-04-26"/>
    <cosponsor bioguide_id="S001168" joined="2021-04-26"/>
    <cosponsor bioguide_id="S001145" joined="2021-08-23"/>
    <cosponsor bioguide_id="S001150" joined="2021-11-09"/>
    <cosponsor bioguide_id="S000185" joined="2021-04-22"/>
    <cosponsor bioguide_id="S001208" joined="2021-05-14"/>
    <cosponsor bioguide_id="S000510" joined="2021-09-17"/>
    <cosponsor bioguide_id="S001200" joined="2021-04-26"/>
    <cosponsor bioguide_id="S001209" joined="2021-06-25"/>
    <cosponsor bioguide_id="S001218" joined="2021-07-20"/>
    <cosponsor bioguide_id="S001215" joined="2022-02-18"/>
    <cosponsor bioguide_id="S001159" joined="2021-07-20"/>
    <cosponsor bioguide_id="S001201" joined="2021-04-26"/>
    <cosponsor bioguide_id="T000460" joined="2021-04-26"/>
    <cosponsor bioguide_id="T000474" joined="2022-08-30"/>
    <cosponsor bioguide_id="T000486" joined="2021-05-20"/>
    <cosponsor bioguide_id="T000483" joined="2022-03-01"/>
    <cosponsor bioguide_id="U000040" joined="2021-05-20"/>
    <cosponsor bioguide_id="W000797" joined="2021-08-03"/>
    <cosponsor bioguide_id="W000187" joined="2021-07-06"/>
    <cosponsor bioguide_id="W000800" joined="2021-04-26"/>
    <cosponsor bioguide_id="W000826" joined="2021-05-14"/>
    <cosponsor bioguide_id="W000788" joined="2021-06-29"/>
    <cosponsor bioguide_id="W000808" joined="2021-04-26"/>
    <cosponsor bioguide_id="Y000062" joined="2021-08-03"/>
  </cosponsors>
  <actions>
    <action datetime="2021-04-22">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-04-22" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-04-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-04-27">
      <text>Referred to the Subcommittee on Oversight and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSVR" name="House Veterans' Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSVR08" name="House Veterans' Affairs" subcommittee="Oversight and Investigations" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSGO" name="House Oversight and Accountability" subcommittee="" activity="Referral"/>
    <committee code="HSED" name="House Education and the Workforce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="2706" relation="unknown"/>
    <bill session="117" type="h" number="4417" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Appropriations"/>
    <term name="Centers for Disease Control and Prevention (CDC)"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Customs enforcement"/>
    <term name="Department of Health and Human Services"/>
    <term name="Department of Labor"/>
    <term name="Department of the Treasury"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Employee benefits and pensions"/>
    <term name="Executive agency funding and structure"/>
    <term name="First responders and emergency personnel"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Government trust funds"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care quality"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Inflation and prices"/>
    <term name="Insurance industry and regulation"/>
    <term name="Manufacturing"/>
    <term name="Marketing and advertising"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Mental health"/>
    <term name="Performance measurement"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Public-private cooperation"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
    <term name="Retail and wholesale trades"/>
    <term name="Sales and excise taxes"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2022-08-23T14:41:04Z" status="Introduced in House">Elijah E. Cummings Lower Drug Costs Now Act

This bill establishes several programs and requirements relating to the prices of prescription drugs.

In particular, the bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs (current law prohibits HHS from doing so). Specifically, HHS must negotiate maximum prices for single-source, brand-name drugs that lack certain generics and that are among either the 125 drugs that account for the greatest national spending or the 125 drugs that account for the greatest Medicare spending. HHS must negotiate the prices of at least 25 such drugs for 2024 and of at least 50 such drugs thereafter and must also negotiate prices for certain newly approved drugs and for insulin products. The negotiated prices must be offered under Medicare and may also be offered under private health insurance unless the insurer opts out.

The negotiated maximum price may not exceed (1) 120% of the average price in Australia, Canada, France, Germany, Japan, and the United Kingdom; or (2) if such information is not available, 85% of the U.S. average manufacturer price. Drug manufacturers that fail to comply with the bill's negotiation requirements are subject to civil and tax penalties.

The bill also makes a series of additional changes to Medicare prescription drug coverage and pricing, including by (1) requiring drug manufacturers to issue rebates to the Centers for Medicare &amp; Medicaid Services for covered drugs that cost $100 or more and for which the average manufacturer price increases faster than inflation, and (2) capping annual out-of-pocket spending under the Medicare prescription drug benefit.

The bill also requires drug manufacturers to report specified information for certain high-cost drugs, and it provides funds for opioid epidemic initiatives and biomedical research.</summary>
</bill>
